Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation
- 19 April 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (17) , 2101-2111
- https://doi.org/10.1038/sj.onc.1204305
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 30 references indexed in Scilit:
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissuesOncogene, 1998
- Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer PatientsBiochemical and Biophysical Research Communications, 1998
- The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligandsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit.Proceedings of the National Academy of Sciences, 1992
- The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound formsCell, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987